Executing an impactful urinary tract cancers strategy – when opportunity grabs you by the hand
In this blog post Aqsens Health’s CEO and Co-founder Timo Teimonen recounts Aqsens’ urinary tract cancer strategy journey and discusses the importance of international collaboration and multidisciplinary approaches in advancing cancer research.
Bladder cancer FAQ – Bladder cancer awareness month 2023
What is bladder cancer and how is it currently diagnosed? How common is it? What are the usual symptoms? Every May the World Bladder Cancer Patient Coalition celebrates bladder cancer awareness month.
Roosa nauha 2022 – Huonoennusteiset syövät
Maria Veitolan suunnittelemassa vuoden 2022 Roosa nauhassa näkyvät rintasyövän vaaleanpunaisen lisäksi myös muiden syöpien tunnusvärit: eturauhassyövän vaaleansininen, lapsuudenajan syövän kultainen, keuhkosyövän valkoinen, sekä esimerkiksi usein vaikean haimasyövän violetti…
Aqsens Health and OG Pharmaceuticals partner for an upcoming collaborative research project – Interview with OG Pharmaceuticals Founder & CEO Dr. Zhao Wanzhou
Dr. Zhao answered shared his views about the upcoming collaboration with Aqsens Health, the benefits of urine-based detection, and applying new cancer screening solutions in China.
Aqsens Health and Turku University Hospital begin a project to assess a novel biosensor method for the early detection of metastatic cancers
Aqsens Health Oy begins a new research collaboration to assess the biosensor method in the detection of different metastatic cancers using urine samples. The BIOURICA research study brings together Aqsens Health Oy’s scientific team and the Turku University Hospital (TYKS) researcher, adjunct professor and Clinical Oncologist Maria Sundvall.